SUMMARY Three patients are presented who sustained bilateral rupture of the Achilles tendon while on systemic steroid therapy for chest disease; a fourth patient with polymyalgia rheumatica on steroids is also presented. This is further evidence that tendon rupture can be a direct complication of steroid treatment. The English-language literature on bilateral Achilles tendon rupture is reviewed.
SUMMARY Three patients are presented who sustained bilateral rupture of the Achilles tendon while on systemic steroid therapy for chest disease; a fourth patient with polymyalgia rheumatica on steroids is also presented. This is further evidence that tendon rupture can be a direct complication of steroid treatment. The English-language literature on bilateral Achilles tendon rupture is reviewed.
Despite many papers discussing the treatment of Achilles tendon rupture few of them mention associated predisposing factors other than trauma or cases of bilateral rupture.' Bilateral rupture of the Achilles tendon is an unusual occurrence, and 4 patients are presented here with this condition.
Case reports CASE 1 An 86-year-old man was referred to the orthopaedic department on 10 April 1981 with bilateral heel pain. The left heel had suddenly become painful while walking 10 days earlier, and 5 A 55-year-old man presented to the medical department with pain in both heels on 3 December 1979. Five days before this he had experienced pain in his left heel followed 3 days later by more severe pain. His right heel started to be painful at the same time.
He was initially thought to be suffering from a deep venous thrombosis, but further examination on the same day showed that he had a complete rupture of the left Achilles tendon. The right Achilles tendon was swollen and tender but without a palpable gap, and there was normal movement of the foot on compression of the calf. This was diagnosed as a partially ruptured Achilles tendon.
He had long-standing chronic obstructive airways disease and for 5 years since 1974 had been taking oral prednisolone varying in dose from 2 to 30 mg daily. His other medication was salbutamol inhaler; beclomethasone inhaler; slow aminophylline; frusemide; and slow potassium tablets. There was no evidence of generalised arthropathy.
The left leg was treated in a short leg equinus plaster for 10 weeks. The right leg was treated by bed rest for 3 weeks until the tender swelling had settled. Full activity was delayed until the plaster was removed. He was then mobilised with inch (1 cm) heel raises. He has had no further problems with his Achilles tendons despite remaining on 15 mg prednisolone daily. CASE 3 A 57 year-old man presented to the orthopaedic outpatient department in May 1981 with a 3-week Bilateral rupture ofthe Achilles tendon in patients on steroid therapy 653 history of pain in both heels. The pain had come on suddenly when he got out of bed one morning and caused difficulty with walking. On examination both Achilles tendons were swollen and tender 2 cm above their insertion, with some associated bruising. Full ankle movements were present, but plantar flexion against resistance gave pain. There was normal movement of the feet on compression of the calf. This was diagnosed as partial rupture of both Achilles tendons.
He had been asthmatic for many years, taking prednisolone 10 mg daily for 12 years since 1969. He was on no other medication, and there was no evidence of generalised arthropathy.
He was treated by reduced activity and heel raises. Complete recovery followed over a period of 5 months. CASE 4 A 79-year-old man was first seen in the orthopaedic outpatient department on 30 April 1982 with a 6-week history of pain behind both heels which had started spontaneously. On examination he had a complete rupture of the left Achilles tendon and a partial rupture of the right-thickened and tender but intact without a gap.
In 1980 he had an adenocarcinoma of the large bowel treated by partial colectomy. There was no evidence of recurrence. In 1981 he developed polymyalgia rheumatica, which was treated with prednisolone. At the time of presentation he had been on a maintenance dose of 5 mg prednisolone daily for one year. He was also taking intermittent indomethacin. There was no evidence of generalised arthropathy.
He was treated with bilateral heel raises, but 3 weeks later examination showed complete rupture of Table 1 presents the relevant details of the 10 cases. Five were associated with chest disease and systemic steroid therapy. Only 3 were associated with a rheumatic disease and steroid therapy, and 2 were healthy individuals. This is different from the situation at the knee,'1 mentioned earlier, and indicates that steroid therapy alone can play a major role in causing bilateral Achilles tendon rupture.
The mechanism of action is uncertain. Several workers have shown that Achilles tendon rupture Steroids probably act by suppressing the repair of degenerated or partially ruptured tendons to such an extent that complete rupture can occur after a minor incident. It does not appear to be related to dose of steroid or length of treatment.
Although Achilles tendon function is not essential for the upright posture or walking, it is still important to appreciate that tendon rupture is a complication of steroid therapy. Thus, as in cases 2 and 3 presented here, measures can be taken to prevent degeneration or partial rupture progressing to complete rupture. Such measures would include stopping steroid therapy if possible, raised heels, or rest in plaster-ofParis as indicated. Case 4 indicates that heel raises are not a particularly effective protection, but they are a reasonable compromise in the elderly patient who would be rendered immobile by a plaster. 
